Journal of Agricultural and Food Chemistry · 2015 · 39 citations · 25 references
MedicineBiochemistryPharmacologyBiochemical PharmacologyDrug MetabolismMetabolismDrug DispositionFirst-pass MetabolismFlavonoid BiosynthesisSpecies Differences In Drug MetabolismFlavonoid MetabolismGlucuronidation PathwaysIntestinal First-pass MetabolismIntestinal Ugt-mediated GlucuronidationTime-varying MetabolismUdp-glucosyltransferase-mediated MetabolismUdp-glucuronosyltransferase Activity
Luteolin is a well-known flavonoid with various pharmacological properties but has low bioavailability due to glucuronidation. This study investigated the time-course of luteolin glucuronidation by 12 human UDP-glucuronosyltransferases (UGTs) and its intestinal first-pass metabolism in mice. Six metabolites, including two novel abundant diglucuronides [3',7-O-diglucuronide (diG) and 4',7-diG] and four known ones, were identified. UGT1A6 and UGT1A9 generated almost only monoglucuronides (G's). The production of 3',7-diG followed a sequential time-dependent process along with decrease of 3'-G mainly by UGT1A1, indicating that 3',7-diG was produced from 3'-G. Metabolism in mice intestine differed from that in humans. Probenecid, a nonspecific UGT inhibitor, did not affect absorption but significantly inhibited production of 7-, 4'-, and 3'-G, and enhanced the formation of another novel metabolite, 5-G, in mice. In conclusion, diglucuronide formation is time-dependent and isoform-specific. UGT1A1 preferentially generates diG, whereas UGT1A6 and UGT1A9 share a preference for G production.
25
Shuji Ohno, Shizuo Nakajin · Drug Metabolism and Disposition · 2008 · 425 citations
Intestinal absorption of luteolin and luteolin 7‐<i>O</i>‐β‐glucoside in rats and humans
Kayoko Shimoi, Hisae Okada, Michiyo Furugori et al. · FEBS Letters · 1998 · 411 citations
David E. Harbourt, John K. Fallon, Shinya Ito et al. · Analytical Chemistry · 2011 · 171 citations